Simvastatin Inhibits the Malignant Behaviors of Gastric Cancer Cells by Simultaneously Suppressing YAP and β-Catenin Signaling

BACKGROUND: Statins, which are used to lower blood cholesterol levels by inhibiting HMG-CoA reductase, have shown anticancer effects in many cancer cells. However, the role of statins in gastric cancer remains unclear. This study aims to investigate whether the statins could antagonize progression o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qing, Xia, Hongwei, Zhou, Sheng, Tang, Qiulin, Zhou, Jitao, Ren, Min, Bi, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074824/
https://www.ncbi.nlm.nih.gov/pubmed/32210573
http://dx.doi.org/10.2147/OTT.S237693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074824/
https://www.ncbi.nlm.nih.gov/pubmed/32210573
http://dx.doi.org/10.2147/OTT.S237693

Ejemplares similares